Picture of Valbiotis SA logo

ALVAL Valbiotis SA Cashflow Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Valbiotis SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-3.83-8.68-12.3-7.37-10
Depreciation
Non-Cash Items0.7121.452.320.5910.825
Unusual Items
Other Non-Cash Items
Changes in Working Capital4.77-0.863-0.053-2.01-2.92
Change in Accounts Receivable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities2.69-7.16-9.19-8.05-11.5
Capital Expenditures-0.331-0.421-0.288-0.247-0.261
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.0010.4140.091-0.0030.2
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-0.332-0.007-0.197-0.25-0.061
Financing Cash Flow Items-0.001
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities4.1914.48.412.5-1.84
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash6.557.24-0.9884.19-13.4